Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-12-02T19:45:57.890Z Has data issue: false hasContentIssue false
  • English
  • Français

A Study of the Etiologies and Treatment of Nosocomial Pneumonia in a Community-Based Teaching Hospital

Published online by Cambridge University Press:  21 June 2016

Charles J. Schleupner  and
David K Cobb
Charles J. Schleupner*
Affiliation:
University of Virginia School of Medicine, Infectious Diseases Section, Department of Veterans Affairs Medical Center, Salem, Virginia
David K Cobb
Affiliation:
Program in Infectious Diseases, University of Virginia Affiliated Hospitals Salem, Virginia
*
Infectious Diseases Section (111L), VA Medical Center, Salem, VA 24153
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To compare the frequency of the pathogens of nosocomial pneumonia in a community-based teaching hospital to the frequencies previously published, and to evaluate recommendations for the therapy of nosocomial pneumonia in this setting.

Design:

Retrospective review of prospectively acquired data accrued during 9 randomized single-blinded and 4 single-agent investigational antibiotic studies for the therapy of pneumonia in hospitalized patients between 1981 and 1989.

Setting:

The study was performed at a university affiliated, community-based teaching Department of Veterans Affairs Medical Center.

Patients:

Patients were hospitalized on the acute medical/surgical and intermediate medicine wards. Informed consent was obtained prior to enrolling patients into the respective antimicrobial studies. Pneumonia was documented radiographicahy and clinically for each patient.

Results:

Two hundred thirty-one episodes of nosocomial pneumonia were treated. Overall, 51% of pneumonias were caused by Streptococcus pneumoniae or Hemophilus influenzae with or without other organisms that were not gram-negative bacilli. Gram-negative bacilli, with or without other organisms, accounted for only 26% of all nosocomial pneumonias. Overall, monotherapy with a cephalosporin (usually a broad-spectrum agent) was equally efficacious compared with combination therapy (87% versus 81%, respectively). Cure rates for nosocomial pneumonias from gram-negative bacilli treated with these 2 therapies also were similar (70% versus 60%, respectively).

Conclusions:

In nontertiary care settings, gram-negative bacilli may cause fewer episodes of nosocomial pneumonia (26% in this study) than noted by previously published reports, which indicated that these organisms account for 50% of nosocomial pneumonias. Further, S pneumoniae and H influenzae may account etiologicahy for many of these nosocomial pneumonias. Monotherapy with an extended-spectrum cephalosporin may be more appropriate than combined treatment with a b-lactam and an aminoglycoside in a nontertiary care setting, thereby reducing potential toxicity in an older, hospitalized patient population.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 13 , Issue 9 , September 1992 , pp. 515 - 525
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Horan, TC, White, JW, Jarvis, WR,, et al. Nosocomial infection surveillance, 1984. Surveillance Summaries. 1984;35(1SS):17SS–29SS.Google Scholar
2. Stamm, WE, Martin, SM, Bennett, JV. Epidemiology of nosocomial infections from gram-negative bacilli: aspectsrelevant todevelopment and use of vaccines. J Infect Dis. 1977;136:S151–S160.CrossRefGoogle ScholarPubMed
3. Craybill, JR, Marshall, LW, Charache, R, Wallace, CK, Melvin, VB. Nosocomial pneumonia: a continuing major problem. Am Rev Respir Dis. 1973;108:1130–1140.Google Scholar
4. Verghese, A, Berk, SL. Bacterial pneumonia in the elderly. Medicine. 1983;62:271–285.CrossRefGoogle ScholarPubMed
5. Bartlett, JG, O'Keefe, P, Tally, FP, Gorbach, SL. Bacteriology of hospital-acquired pneumonia. Arch Intern Med. 1986;146:868–871.CrossRefGoogle ScholarPubMed
6. Hessen, MT Kaye, D. Nosocomial pneumonia. Crit Care Clin. 1988;4:245–257.CrossRefGoogle ScholarPubMed
7. Septimus, EJ. Nosocomial bacterial pneumonias. Sem Respir Infect 1989;4:245–252.Google ScholarPubMed
8. Ruiz-Santana, S, Jimenez, AG, Esteban, S, et al. ICU pneumonias: a multi-institutional study. Crit Care Med. 1987;15:930–932.CrossRefGoogle ScholarPubMed
9. Potgieter, PD, Linton, DM, Oliver, S, et al. Nosocomial infections in arespiratory intensive care unit. Crit Care Med. 1987;15:495–498.CrossRefGoogle Scholar
10. Berk, SL, Gallemore, GM, Smith, JK. Nosocomial pneumococcal pneumonia in the elderly. J Am Ger Society. 1981;29:319–321.CrossRefGoogle ScholarPubMed
11. Simon, HB, Southwick, FS, Moellering, RC Jr, Sherman, E. Hemophilus influenzae in hospitalized adults: current perspectives . Am J Med. 1980;69:219–226.CrossRefGoogle ScholarPubMed
12. Alvarez, S, Guarderas, J, Shell, CG, Holtsclaw-Berk, S, Berk, SL. Nosocomial pneumococcal bacteremia. Arch Intern Med. 1986;146:1509–1512.CrossRefGoogle ScholarPubMed
13. Tbwes, GB. Southwestern internal medicine conference: nosocomial pneumonia. Am J Med Sci. 1986;291:355–367.Google Scholar
14. Stratton, CW. Bacterial pneumonias-an overview with emphasis on pathogenesis, diagnosis, and treatment. Heart Lung. 1986;15:226–244.Google Scholar
15. Pennington, JE. Hospital-acquired pneumonia In: Wenzel, RP, ed. Prevention and Control of Nosocomial Infections. Baltimore, Md: Williams and Wilkins; 1987:321–334.Google Scholar
16. Moore, RD, Smith, CR, Lietman, PS. Association of aminoglyco-side plasma levels with therapeutic outcome in gram-negative pneumonia. Am J Med. 1984:77:657–662.CrossRefGoogle ScholarPubMed
17. Schleupner, CJ, Engle, JC. Clinical evaluation of cefotaxime for therapy of lower respiratory tract infection. Antimicrob Agents Chemother. 1982;21:327–333.CrossRefGoogle Scholar
18. Engle, JC, Liiand, PW, Schleupner, CJ. Comparison of ceftazidime to cefamandole for the therapy of community-acquired pneumonias. Antimicrob Agents Chemother. 1985;28:146–148.CrossRefGoogle Scholar
19. Schleupner, CJ, Anthony, WC, Tan, J, et al. Multicenter single-blinded comparison of cefuroxime to cefaclor in the therapy of lower respiratory tract infections in adults. Arch Intern Med. 1988;148.343–348.CrossRefGoogle Scholar
20. Murray, PR, Washington, JA II. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clinic Proc. 1975;50:339–344.Google Scholar
21. Geckler, RW, Gremillion, DH, McAllister, CK, Ellenbogen, C. Microscopic and bacteriological comparison of paired sputa and transtracheal aspirates. J Clin Microbial. 1977;6:396–399.CrossRefGoogle ScholarPubMed
22. Louria, DB, Kaminski, T The effects of four antimicrobial drug regimens on sputum super-infection in hospitalized patients. Am Rev Resp Dis. 1962;85:649–665.Google Scholar
23. Gherman, CR, Simon, HJ. Pneumonia complicating severe underlying disease. Disease of the Chest. 1965:48:297–304.CrossRefGoogle ScholarPubMed
24. Pierce, AK, Edmonson, EB, McGee, G, Ketchersid, J, London, RG, Sanford, JP, An analysis of factors predisposing to gram-negative bacillary necrofizing pneumonia. Am Rev Resp Dis. 1966;94:309–315.Google ScholarPubMed
25. Tilloston, JR, Finland, M. Secondary pulmonary infections following antibiotic therapy for primary bacterial pneumonia. Antimicrob Agents Chemother. 1968;8:326–330.Google Scholar
26. Johanson, WG, Pierce, AK, Sanford, JF! Changing pharyngeal bacterial flora of hospitalized patients. N Engl J Med. 1969;281:1137–1140.CrossRefGoogle ScholarPubMed
27. Tillotson, JR, Finland, M. Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of Qneumonia. I Infect Dis. 1969;119:597–624.CrossRefGoogle Scholar
28. Johanson, WG, Pierce, AK, Sanford, JP, Thomas, GD. Nosocomial respiratory infection with gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med. 1972;77:701–706.CrossRefGoogle ScholarPubMed
29. Pierce, AK, Sanford, JR Aerobic gram-negative bacillary pneumonias. Am Rev Resp Dis. 1974;110:647–658.Google ScholarPubMed
30. Valenti, WM, Tiudell, RG, Bentley, DW. Factors predisposing to oropharyngeal colonization with gram-negative bacilli in the aged. N Engl J Med 1978;298:1108–1111.CrossRefGoogle ScholarPubMed
31. LaForce, FM. Hospital acquired-n-am-nggative rod nneumonias: an overview. Am J Med. 1981;70:664–669.CrossRefGoogle ScholarPubMed
32. Craven, DE, Driks, MR. Nosocomial pneumonia in the intubated patient. Semin Resp Infect. 1987;2:20–33.Google ScholarPubMed
33. Mylotte, JM, Beam, TR Jr. Comparison of community-acquired and nosocomial pneumonia bacteremia. Am Rev Resp Dis. 1981;123:265–268.Google Scholar
34. Levison, ME, Kaye, D. Pneumonia caused by gram-negative bacilli: an overview. Rev Infect Dis. 1985;7(S4):S656–S665.CrossRefGoogle ScholarPubMed
35. Garb, JL, Brown, RB, Garb, JR, Tuthill, RW. Differences in etiology of pneumonias in nursing home and community patients. JAMA. 1978;240:2169–2172.CrossRefGoogle ScholarPubMed
36. Elbright, JR, Rytel, NW Bacterial pneumonia in the elderly. J Am Ger Soc. 1980:36:220–223.CrossRefGoogle Scholar
37. Norman, DC, Castle, SC, Cantrell, M. Infections in the nursing home. Am Ger Soc. 1987;35:796–805.CrossRefGoogle ScholarPubMed
38. Barrett-Connor, E. The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia. Am Rev Resp Dis. 1971;103:845–848.Google Scholar
39. Rein, ME Gwaltney, JM, O'Brien, WM, Jennings, RH, Mandell, GL. Accuracy of gram's stain in identifying pneumococci in sputum. JAMA. 1978;239:2671–2673.CrossRefGoogle ScholarPubMed
40. Gardner, WG. Multicentered clinical evaluation of cefoperazone for the treatment of lower respiratory tract infections. Rev Infect Dis. 1983:5:S137–S144.CrossRefGoogle ScholarPubMed
41. Perkins, RL. Clinical trials of cefotaxime for the treatment of bacterial infections of the lower respiratory tract. Rev Infect Dis. 1982;4:S421–S431.CrossRefGoogle ScholarPubMed
42. Mangi, RJ, Greco, T, Ryan, J, Thornton, G, Andriole, VT Cefopera-zone versus combinaton antibiotic therapy of hospital-acquired pneumonia. Am J Med. 1988;84:68–74.CrossRefGoogle Scholar
43. Warren, JW, Miller, EH, Fitzpatrick, B et al. A randomized, controlled trial of cefoperazone vs. cefamandole-tobramyacin in the treatment of putative, severe infections with gram-negative bacilli. Rev Infect Dis. 1983;5(suppl):S173–S180.CrossRefGoogle ScholarPubMed
44. Trenholme, GM, Pottage, JC, Karakusis, PH. Use of ceftazidime in the treatment of nosocomial lower respiratory infections. Am J Med. 1985;79(S2A):32–36.CrossRefGoogle ScholarPubMed
45. Mangi, RJ, Ryan, J, Berenson, C, et al. Cefoperazone versus ceftazidiie monotherapy of nosocomial pneumonia. Am J Med. 1988;95(S1A):44–48.CrossRefGoogle Scholar
46. LaForce, FM. Systemic antimicrobial therapy of nosocomial pneumonia: monotherapy versus combination therapy. Eur J Clin Microbiol Infect Dis. 1989;8:61–68.CrossRefGoogle ScholarPubMed